IP Library Granted Patent US 7,223,879
Granted Patent B2
US 7,223,879 · App. 10/731,702 · Granted May 29, 2007

Ligands for metals and improved metal-catalyzed processes based thereon

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,879
App. No.
10/731,702
Granted
May 29, 2007
Kind
B2
Abstract

One aspect of the present invention relates to ligands for transition metals. A second aspect of the present invention relates to the use of catalysts comprising these ligands in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions. The subject methods provide improvements in many features of the transition metal-catalyzed reactions, including the range of suitable substrates, reaction conditions, and efficiency.

Claims (46)

1. A ligand represented by structure I:

wherein

R is selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, and —(CH 2 ) m —R 80 ;

the A and A′ rings of the biphenyl core independently may be unsubstituted or substituted with R 1 and R 2 , respectively, any number of times up to the limitations imposed by stability and the rules of valence;

R 1 and R 2 , when present, are selected independently for each occurrence from the group consisting of ethyl, propyl, butyl, pentyl, hexyl, cycloalkyl, heterocycloalkyl, heteroaryl, aralkyl, heteroaralkyl, —Si(R) 3 , and —(CH 2 ) m —R 80 ;

R 80 represents an unsubstituted or substituted aryl, a cycloalkyl, a cycloalkenyl, a heterocycle, or a polycycle;

m is independently for each occurrence an integer in the range 0 to 8 inclusive; and

the ligand, when chiral, is a mixture of enantiomers or a single enantiomer.

2. The ligand of claim 1 , wherein R represents independently for each occurrence ethyl, propyl, butyl, pentyl, hexyl, cycloalkyl or aryl; at least two instances of R 2 are present; and R 2 is selected independently for each occurrence from the group consisting of ethyl, propyl, butyl, pentyl, hexyl, and cycloalkyl.

3. A ligand represented by structure II:

wherein

R is selected independently for each occurrence from the group consisting of cycloalkyl, and —(CH 2 ) m —R 80 ;

R′ is selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, and —(CH 2 ) m —R 80 ;

the A and A′ rings of the biphenyl core independently may be unsubstituted or substituted with R 1 and R 2 , respectively, any number of times up to the limitations imposed by stability and the rules of valence;

R 1 and R 2 , when present, are selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, halogen, —Si(R) 3 , and —(CH 2 ) m —R 80 ;

R 80 represents independently for each occurrence cycloalkyl or aryl;

m is independently for each occurrence an integer in the range 0 to 8 inclusive; and

the ligand, when chiral, is a mixture of enantiomers or a single enantiomer.

4. The ligand of claim 3 , wherein R 1 is absent; and R 2 is absent.

5. The ligand of claim 3 , wherein R represents independently for each occurrence cycloalkyl.

6. The ligand of claim 3 , wherein R represents independently for each occurrence, cyclohexyl, or cyclopropyl.

7. The ligand of claim 3 , wherein R represents independently for each occurrence cyclohexyl.

8. The ligand of claim 3 , wherein R′ represents independently for each occurrence alkyl.

9. The ligand of claim 3 , wherein R′ represents independently for each occurrence isopropyl.

10. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; and R represents independently for each occurrence cycloalkyl.

11. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; and R represents independently for each occurrence cyclohexyl, or cyclopropyl.

12. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; and R represents independently for each occurrence cyclohexyl.

13. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence cycloalkyl; and R′ represents independently for each occurrence alkyl.

14. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence cyclohexyl, or cyclopropyl; and R′ represents independently for each occurrence alkyl.

15. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence cyclohexyl; and R′ represents independently for each occurrence alkyl.

16. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence or cycloalkyl; and R′ represents independently for each occurrence isopropyl.

17. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence cyclohexyl, or cyclopropyl; and R′ represents independently for each occurrence isopropyl.

18. The ligand of claim 3 , wherein R 1 is absent; R 2 is absent; R represents independently for each occurrence cyclohexyl; and R′ represents independently for each occurrence isopropyl.

19. A ligand represented by structure III:

wherein

R′ is selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, and —(CH 2 ) m —R 80 ;

the A and A′ rings of the biphenyl core independently may be unsubstituted or substituted with R 1 and R 2 , respectively, any number of times up to the limitations imposed by stability and the rules of valence;

R 1 and R 2 , when present, are selected independently for each occurrence from the group consisting of alkyl, cycloalkyl, halogen, —Si(R) 3 , and —(CH 2 ) m —R 80 ;

R 80 represents independently for each occurrence cycloalkyl or aryl;

m is independently for each occurrence an integer in the range 0 to 8 inclusive; and

the ligand, when chiral, is a mixture of enantiomers or a single enantiomer.

20. The ligand of claim 19 , wherein R 1 is absent; and R 2 is absent.

21. The ligand of claim 19 , wherein R′ represents independently for each occurrence alkyl.

22. The ligand of claim 19 , wherein R′ represents independently for each occurrence isopropyl.

23. The ligand of claim 19 , wherein R 1 is absent; R 2 is absent; and R′ represents independently for each occurrence alkyl.

24. The ligand of claim 19 , wherein R 1 is absent; R 2 is absent; and R′ represents independently for each occurrence isopropyl.

Assignments (4)
CONFIRMATORY LICENSE Recorded Dec 29, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 027463/0727 →
CONFIRMATORY LICENSE Recorded Aug 15, 2011
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 026749/0433 →
CONFIRMATORY LICENSE Recorded Aug 10, 2009
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 023071/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2004
From: BUCHWALD, STEPHEN L.; HUANG, XIAOHUA; ZIM, DANILO
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 014596/0164 →
Continuity (7)
Continuation In Part 1042095000 · Apr 22, 2003
Division 1000410100 · Oct 23, 2001
Continuation 0923131500 · Jan 13, 1999
Continuation In Part 0911347800 · Jul 10, 1998
Provisional Application 6045156200 · Mar 3, 2003
Provisional Application 6043187000 · Dec 9, 2002
Related Publication 20040171833A1 · Sep 2, 2004